Kokou Atchou

Dr. Kokou Atchou

University of Lome
+1
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2021 in Bulletin of the National Research Centre
Verified
Journal Article
Open access
PDF file
Kokou AtchouKokou Atchou
Kokou Atchou
PLPovi Lawson-Evi
Povi Lawson-Evi
KEKwashie Eklu-Gadegbeku
Kwashie Eklu-Gadegbeku
Background: Cataracts and glomerulopathy are disabling complications of diabetes mellitus. The use of medicinal plants in the treatment of diabetes helps prevent or delay these complications. Pterocarpus erinaceus and Amaranthus spinosus are part of these medicinal plants used in traditional medicine to treat diabetes and its complications. The aim of this study was to evaluate in vitro the protective effect of the dried hydroethanolic extracts of the two plants against cataractogenesis and glomerulopathy induced by high glucose. Lenses and kidney fragments from Sprague–Dawley rats were cultured in artificial aqueous humor and in glomerular solution under high glucose, respectively. The extracts of the two plants at doses of 250 and 500 mg/kg bw were added to the culture medium and incubated for 72 h for the lenses and 96 h for the kidney fragments. Morphological and biochemical parameters were evaluated during the cultures. Results: The lenses treated with extracts of both plants remained shiny and transparent in contrast to the opacity observed in toxic controls. The treatment by extract caused a significant (p < 0.001) decrease in malondialdehyde and a significant increase (p < 0.001) in glutathione and catalase levels in lenses and kidney fragments. The extracts also caused a significant increase (p < 0.0001) in glucose absorption in glomeruli and a decrease in tubular glucose reabsorption in kidney fragments. This led to a decrease in glucose in the incubation medium. Conclusion: These findings showed that the dried hydroethanolic extract of P. erinaceus and A. spinosus can be used to reduce hyperglycemia effects by inhibiting oxidative stress pathways and then preventing or delaying the onset of cataracts and kidney failure in diabetes.

1 November 2021 in Phytomedicine Plus
Verified
Journal Article
Open access
Kokou AtchouKokou Atchou
Kokou Atchou
PLPovi Lawson-Evi
Povi Lawson-Evi
KEKwashie Eklu-Gadegbeku
Kwashie Eklu-Gadegbeku

21 July 2021 in Clinical Phytoscience
Verified
Journal Article
Open access
PDF file
Kokou AtchouKokou Atchou
Kokou Atchou
PLPovi Lawson-Evi
Povi Lawson-Evi
DADIALLO Aboudoulatif
DIALLO Aboudoulatif
KEKwashie Eklu-Gadegbeku
Kwashie Eklu-Gadegbeku
Background: Amaranthus spinosusis a medicinal plant used in traditional medicine to treat several diseases including diabetes and its complications. The aim of this study was to prove the safety of the plant in animal health.Methods: The dry extract was obtained following the hydroethanolic extraction ofA. spinosusroots. The cytotoxicity was evaluatedin vitroby incubatingArtemia salinalarvae with the extract for 24 h.In vivotoxicity was assessed in Sprague Dawley rats. A single dose of 5000 mg/kg bw of extract was administered orally to female rats in acute toxicity and observed for 14 days for mortality and signs of toxicity. In subchronic toxicity, extract doses of 500 and 1000 mg/kg bw were administered orally to male and female rats for 28 consecutive days and observed for previous signs. Body weight was recorded daily and blood glucose levels every week. On day 29, blood was collected for biochemical and hematological studies. Organs were then exised for gross autopsy and histopathological examination.Results: Thein vitrostudy showed that the extract had a LC50 = 1.178 mg/mL in larvae and was considered to be non-cytotoxic. Oral administration of extract at a single dose of 5000 mg/kg bw did not cause any mortality or sign of toxicity in gross necropsy. In subchronic oral toxicity, repeated doses of 500 and 1000 mg/kg bw of extract, did not also cause any mortality or significant change in body weight, relative weight of vital organs. Furthermore, hematological and biochemical parameters and histopathological examination did not show any significant change. The observed decrease in blood glucose levels did not correlate with organ damage and supports the safety of the plant. However, the reduction of LDL-cholesterol has shown that the extract can prevent cardiovascular disease.Conclusions: This finding demonstrated thatA. spinosusroot is non-toxic with a LD50 > 5000 mg/kg bw. Thus, the extract can be used for cutaneous and subchronic oral administration at doses ≤ 1000 mg/kg bw. However, further studies such as embryo/fetotoxicity, genotoxicity and neurotoxicity will be needed to prove the safety of chronic administration of the extract in patients and fetuses.

2 September 2023 in Biochemistry and Biophysics Reports
Verified
Journal Article
Open access
Kokou AtchouKokou Atchou
Kokou Atchou
PLPovi Lawson-Evi
Povi Lawson-Evi
KEKwashie Eklu-Gadegbeku
Kwashie Eklu-Gadegbeku
Pterocarpus erinaceus Poir. from Fabaceae family is a medicinal plant traditionally used in decoction or infusion to treat diabetes mellitus. Although this plant is used in treating diabetes, studies on the effectiveness of its stem bark on the complications induced by chronic hyperglycemia have not been thoroughly addressed. Thus, this study was conducted to prove the efficacy of hydroethanolic extract of stem bark of P. erinaceus on type 2 diabetes and its complications, such as renal fibrosis and retinopathy in rats. STZ diabetics. The dry extract of P. erinaceus stem bark was obtained following the hydroethanolic extraction (v/v). Diabetes was induced with streptozocin in SD rats pretreated with fructose-lard for 20 days. Then, the serum and urinary biochemical parameters were evaluated at the start and the end of the treatment. Rats with blood glucose ≥350 mg/dL and significant proteinuria were selected and treated with P. erinaceus stem bark extract and glibenclamide for 3 weeks. A complete blood count and a histopathological examination of the retina and kidneys were performed at the end of the 41st day of treatment. The results showed that P. erinaceus extract at a dose of 500 mg/kg bw and glibenclamide at a dose of 0.6 mg/kg bw caused a significant decrease (p < 0.0001) in basal blood glucose in STZ diabetic rats during treatment and improved oral glucose intolerance. At the end of the experiment, the treated rats showed a normalization in body weight, food and water consumption. Evaluating of biochemical parameters showed a significant (p < 0.001) decrease in total cholesterol, LDL-C, triglycerides, TG/HDL-C ratio, CPK and oxidative stress in treated rats. No retinal and kidney abnormalities were observed on histological sections in rats treated with plant extract and glibenclamide. In contrast, macular edema and renal fibrosis were observed in the diabetic control group. The findings showed that extract at a dose of 500 mg/kg bw improves oral glucose intolerance, and inhibits lipid deposition and retinal and renal fibrosis. Therefore, the plant extract could be exploited in the production of herbal medicines to manage diabetes and its complications.

1 June 2026 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Open access
MMManjunath Madalageri
Manjunath Madalageri
VSVeeresh Sadashivanavar
Veeresh Sadashivanavar
RKRaghavendra Kinnal
Raghavendra Kinnal
Kokou AtchouKokou Atchou
Kokou Atchou
KPK. Sreedhara Ranganath Pai
K. Sreedhara Ranganath Pai
The most aggressive and treatment-resistant primary brain malignancy is glioblastoma (GBM). It spreads widely throughout the brain, grows rapidly, and often does not respond to conventional therapies. The aberrant activation of SRC, a non-receptor tyrosine kinase, is a major factor in GBM development. The SRC Paradox, a sharp divergence in which strong molecular suppression in vitro fails to translate into clinical efficacy because of the blood-brain barrier's (BBB) restrictive kinetics, has historically hampered the translational trajectory of SRC inhibitors in GBM. This paper reassesses the SRC tyrosine kinase as a crucial orchestrator of GBM invasiveness, whose therapeutic potential remains constrained by physiological barriers rather than merely acting as a redundant signaling node. To overcome this translational impasse, we propose the crucial integration of bilosomes, which are bile-salt-stabilized vesicular nanocarriers. In contrast to conventional liposomal systems, bilosomes' distinct amphiphilic structure and greater membrane flexibility may enhance BBB permeation and cellular uptake while protecting SRC inhibitors from metabolic breakdown and systemic sequestration. We also analyze the molecular interactions between the glioma microenvironment and bilosomal surface functionalization. This review lays a rigorous foundation for the next generation of CNS-specific nanomedicines by integrating current advances in bilosomal pharmacokinetics with the basic biology of SRC-mediated oncogenic signaling, turning the "SRC Paradox" into a solid clinical reality.

24 October 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
Kokou AtchouKokou Atchou
Kokou Atchou
PLPovi Lawson-Evi
Povi Lawson-Evi
KEKwashie Eklu-Gadegbeku
Kwashie Eklu-Gadegbeku
Diabetes complications appear with the severity of hyperglycemia and the age of the disease. In type 2 diabetes mellitus (T2DM), herbal medicines are also effective in reducing hyperglycemia and can be used for this purpose to manage complications. This study aimed to prove the effectiveness of Amaranthus spinosus root extract on type 2 diabetes (T2D) and its microvascular complications. A high-fat diet and low-dose streptozocin were used for 20 days to induce T2D syndrome and complications in rats. The validated animal models were treated orally with the dried hydroethanolic extract of A. spinosus for three weeks; then the hematological, biochemical, and histological markers were evaluated. The results showed that the extract at a dose of 500 mg/kg bw was effective against diabetes and its complications. This effectiveness was linked to a significant reduction (p < 0.0001) in basal blood glucose, tissue oxidative stress, serum cardiovascular and hepato-renal markers, and an improvement in insulin secretion and utilization. The protective activity of the extract against macular edema and renal fibrosis was confirmed by histopathological examinations. These findings prove that A. spinosus root extract contains bioactive compounds that may be useful in preventing or reversing diabetic retinopathy and renal fibrosis.